discerningdem
Tuesday, August 31, 2021
Johnson & Johnson Stops HIV Vaccine Trial In African Women
Johnson & Johnson Stops HIV Vaccine Trial In African Women
: Johnson & Johnson (NYSE: JNJ) and a consortium of global partners announced results from the primary analysis of a Phase 2b HIV vaccine trial, Imbokodo study....
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment